EP #443: Overmedicating in the New CAA Environment — with Mark A. Smith

This week's episode delves into the world of pharmacogenomics (PGx) and how it is changing the way we approach medication management. We sit down with a leading expert in the field to discuss the current state of PGx adoption, the challenges it faces in gaining wider acceptance in the medical community, and the potential impact it could have on our healthcare system in the future. From the role of direct-to-consumer testing to the importance of involving clinicians in the decision-making process, we explore the complexities of this emerging field and what it could mean for patient care. Join us for this informative and thought-provoking conversation on the cutting edge of personalized medicine.What You’ll Learn From This Episode:1:54 Overmedication: A systemic problem in healthcare.4:16 The evolution and future of pharmacogenetics (PGx) as a standard of care.12:44 Implementing pharmacogenomics testing in employer healthcare plans: Overcoming adoption challenges and practical applications.14:51 The adoption curve of pharmacogenomics testing in healthcare: A bottom-up mission.17:34 The future of PGx: Adoption by early adopters and the role of payers.Enjoy The Show?Don't miss an episode, subscribe via iTunes, Stitcher or RSS.Leave us a review in iTunes (here's how)Join the conversation by leaving a comment below!